Antitumor activity of an EpCAM/CD3-bispecific BiTE antibody during long-term treatment of mice in the absence of T-cell anergy and sustained cytokine release.
J Immunother
; 32(5): 452-64, 2009 Jun.
Article
in En
| MEDLINE
| ID: mdl-19609237
Full text:
1
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Cell Adhesion Molecules
/
CD3 Complex
/
Antibodies, Bispecific
/
Immunotherapy
/
Mammary Neoplasms, Experimental
/
Antigens, Neoplasm
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Year:
2009
Type:
Article